Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-01

Clinical Trial Update: Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating celecoxib for inhibition of aromatase expression and inflammation in adipose tissue of obese postmenopausal women has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

Sponsor: Rockefeller University | Conditions: Obesity | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-02-01